Margaret A. Alexander

CIK: 0002036798

Transaction Breakdown

Open Market Buys (P)1 (14.3%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OVID

Ovid Therapeutics Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

OVID
Ovid Therapeutics Inc.
Feb 26, 2026
Award(A)
Employee Stock Option (Right to Buy)
Direct
1.4M shares-
OVID
Ovid Therapeutics Inc.
Feb 23, 2026
Sale(S)
Direct
11.7K shares at avg. $1.45$17K
OVID
Ovid Therapeutics Inc.
Jan 4, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
890K shares-
OVID
Ovid Therapeutics Inc.
Feb 26, 2025
Sale(S)
Direct
5.3K shares at avg. $0.56$3K
OVID
Ovid Therapeutics Inc.
Feb 20, 2025
Award(A)
Direct
43.8K shares-
OVID
Ovid Therapeutics Inc.
Jan 27, 2025
Purchase(P)
Direct
6.8K shares at avg. $0.73$5K
OVID
Ovid Therapeutics Inc.
Sep 9, 2024
Award(A)
Employee Stock Option (right to buy)
Direct
140K shares-

		Type	Shares	Price		Ownership
Feb 26, 2026	OVID Ovid Therapeutics Inc.	Award(A) Employee Stock Option (Right to Buy)	1,435,000	-	-	Direct
Feb 23, 2026	OVID Ovid Therapeutics Inc.	Sale(S)	11,656	$1.45	$16,901	Direct
Jan 4, 2026	OVID Ovid Therapeutics Inc.	Award(A) Employee Stock Option (right to buy)	890,000	-	-	Direct
Feb 26, 2025	OVID Ovid Therapeutics Inc.	Sale(S)	5,279	$0.56	$2,956	Direct
Feb 20, 2025	OVID Ovid Therapeutics Inc.	Award(A)	43,750	-	-	Direct
Jan 27, 2025	OVID Ovid Therapeutics Inc.	Purchase(P)	6,810	$0.73	$4,971	Direct
Sep 9, 2024	OVID Ovid Therapeutics Inc.	Award(A) Employee Stock Option (right to buy)	140,000	-	-	Direct

1-7 of 7 transactions

About ALEXANDER MARGARET A.

ALEXANDER MARGARET A. (SEC CIK 0002036798) files insider reports with the SEC as President and CEO of Ovid Therapeutics Inc. (OVID).

Signal8 holds 7 ownership filings by ALEXANDER MARGARET A. (1 Form 3, 6 Form 4), filed between Sep 11, 2024 and Mar 2, 2026. Those filings report 7 transactions, from Sep 9, 2024 to Feb 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on ALEXANDER MARGARET A.'s filings is in NEW YORK, NY.

Recent filings by ALEXANDER MARGARET A.

Feb 26, 2026: Grant or award of OVID derivative securities (Form 4, code A).
Feb 23, 2026: Open-market sale of OVID shares (Form 4, code S).
Jan 4, 2026: Grant or award of OVID derivative securities (Form 4, code A).
Feb 26, 2025: Open-market sale of OVID shares (Form 4, code S).
Feb 20, 2025: Grant or award of OVID shares (Form 4, code A).

Other insiders filing for Ovid Therapeutics Inc. (OVID)

Carter Charles Ross, Chief Financial Officer
Greka Anna, Director
PAPADOPOULOS STELIOS, Director
Friedman Bart, Director
Fitzgerald Kevin Joseph, Director
LEVIN JEREMY M, Director

How to read Form 4 transaction codes